SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales for the June 2025 quarter moved down to Rs. 15.19 millions as compared to Rs. 17.95 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -12.90 millions as compared to Net Loss of Rs. -8.57 millions of corresponding quarter ended June 2024 Operating profit Margin for the quarter ended June 2025 further decreased to -11.11% as compared to -7.06% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 15.19 17.95 -15.38 15.19 17.95 -15.38 100.75 102.88 -2.07
Other Income 0.00 0.71 0.00 0.00 0.71 0.00 4.41 3.33 32.43
PBIDT -11.11 -7.06 57.37 -11.11 -7.06 57.37 -35.88 -32.39 10.77
Interest 1.93 2.82 -31.56 1.93 2.82 -31.56 9.64 12.20 -20.98
PBDT -13.04 -9.88 31.98 -13.04 -9.88 31.98 -45.52 -44.59 2.09
Depreciation 1.76 1.83 -3.83 1.76 1.83 -3.83 7.38 7.20 2.50
PBT -14.80 -11.71 26.39 -14.80 -11.71 26.39 -52.90 -51.79 2.14
TAX -1.90 -3.14 -39.49 -1.90 -3.14 -39.49 -6.41 -6.65 -3.61
Deferred Tax -1.90 -3.14 -39.49 -1.90 -3.14 -39.49 -10.71 -6.65 61.05
PAT -12.90 -8.57 50.53 -12.90 -8.57 50.53 -46.49 -45.14 2.99
Equity 123.10 123.10 0.00 123.10 123.10 0.00 123.10 94.33 30.50
PBIDTM(%) -73.14 -39.33 85.96 -73.14 -39.33 85.96 -35.61 -31.48 13.12

Vista Pharma Share Price

7.19 -0.32 (-4.26%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×